Cancer Screening Participation Reaches Two Thirds of Eligible Residents in Flanders
Government health officials send approximately 1.5 million preventive testing invitations annually to residents across Flanders to detect breast, cervical, and colorectal cancers early. According to data, two-thirds of those invited participate in the free screenings. However, participation drops among specific demographics, and roughly one in three eligible individuals leaves the invitation unread or sets it aside.
Dr. Patrick Martens of the Center for Cancer Detection (CvKO) noted that the program aims to reach people who feel completely healthy before symptoms develop. About 95 percent of participants receive all-clear results, while those diagnosed early benefit from higher treatment success rates.
Age Groups and Target Frequencies for Three Screening Programs
The government-organized programs target specific age ranges and intervals based on risk factors associated with aging. Women aged 50 to 69 receive invitations every two years for a mammogram, which is an X-ray designed to detect tumors early. Reported data shows that participating women face up to a half-lower risk of dying from breast cancer compared to non-participants.
Cervical cancer screenings use Pap smears and human papillomavirus (HPV) testing. Women aged 25 to 29 are tested every three years for abnormal cells. For women aged 30 to 64, labs screen first for high-risk HPV strains every five years, as persistent infections can cause cellular changes over time.
Colorectal cancer screening involves a mailed fecal immunochemical test (FIT) sent every two years to both men and women aged 50 to 74. Participants collect a tiny stool sample at home to check for invisible traces of blood. While fewer than one in 10 abnormal tests indicate cancer, four in 10 reveal polyps that can be removed during a follow-up colonoscopy before turning malignant.
Socioeconomic Barriers and Psychological Hesitation Delay Testing
Financial stress, language barriers, and daily obligations cause many individuals to ignore the test kits. Martens explained that people facing immediate hardships struggle to prioritize a disease that might not materialize for a decade.
Potential Risks of False Positives and Overdiagnosis
Screening tests are not diagnostic tools and carry limitations, including false-positive results that cause temporary anxiety before follow-up exams disprove the initial finding.
The Critical Importance of Completing Follow-Up Evaluations
Receiving an abnormal result requires immediate further investigation to ensure the screening serves its purpose. Data from the Center for Cancer Detection shows that 14 percent of people with an abnormal stool test fail to schedule the necessary follow-up colonoscopy. By contrast, only three percent of women skip follow-up care after an abnormal breast cancer screening.
Related reading